These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8784237)

  • 1. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.
    Loddick SA; Rothwell NJ
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):932-40. PubMed ID: 8784237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat.
    Stroemer RP; Rothwell NJ
    J Cereb Blood Flow Metab; 1997 Jun; 17(6):597-604. PubMed ID: 9236716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat.
    Stroemer RP; Rothwell NJ
    J Cereb Blood Flow Metab; 1998 Aug; 18(8):833-9. PubMed ID: 9701344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.
    Mulcahy NJ; Ross J; Rothwell NJ; Loddick SA
    Br J Pharmacol; 2003 Oct; 140(3):471-6. PubMed ID: 12970087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat.
    Relton JK; Martin D; Thompson RC; Russell DA
    Exp Neurol; 1996 Apr; 138(2):206-13. PubMed ID: 8620919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist.
    Yang GY; Liu XH; Kadoya C; Zhao YJ; Mao Y; Davidson BL; Betz AL
    J Cereb Blood Flow Metab; 1998 Aug; 18(8):840-7. PubMed ID: 9701345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous interleukin-1 receptor antagonist is neuroprotective.
    Loddick SA; Wong ML; Bongiorno PB; Gold PW; Licinio J; Rothwell NJ
    Biochem Biophys Res Commun; 1997 May; 234(1):211-5. PubMed ID: 9168991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury.
    Sanderson KL; Raghupathi R; Saatman KE; Martin D; Miller G; McIntosh TK
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1118-25. PubMed ID: 10532636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous mast cell degranulation in rats receiving injections of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) and/or its vehicle: possible clinical implications.
    Bendele A; Colloton M; Vrkljan M; Morris J; Sabados K
    J Lab Clin Med; 1995 Apr; 125(4):493-500. PubMed ID: 7706905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain.
    Betz AL; Yang GY; Davidson BL
    J Cereb Blood Flow Metab; 1995 Jul; 15(4):547-51. PubMed ID: 7790404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attenuation of reperfusion injury in the mouse transfected interleukin-1 receptor antagonist].
    Mao Y; Zhou L; Yang G
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):698-701. PubMed ID: 11798839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased survival in experimental rat heatstroke by continuous perfusion of interleukin-1 receptor antagonist.
    Chiu WT; Kao TY; Lin MT
    Neurosci Res; 1996 Jan; 24(2):159-63. PubMed ID: 8929922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia.
    Martin D; Chinookoswong N; Miller G
    Exp Neurol; 1994 Dec; 130(2):362-7. PubMed ID: 7867766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-ischemic treatment of pentoxifylline reduces cortical not striatal infarct volume in transient model of focal cerebral ischemia in rat.
    Vakili A; Zahedi khorasani M
    Brain Res; 2007 May; 1144():186-91. PubMed ID: 17320054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat.
    Loddick SA; Turnbull AV; Rothwell NJ
    J Cereb Blood Flow Metab; 1998 Feb; 18(2):176-9. PubMed ID: 9469160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat.
    Allan SM; Parker LC; Collins B; Davies R; Luheshi GN; Rothwell NJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5580-5. PubMed ID: 10779559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose- and time-dependence of L-NAME neuroprotection in transient focal cerebral ischaemia in rats.
    Margaill I; Allix M; Boulu RG; Plotkine M
    Br J Pharmacol; 1997 Jan; 120(1):160-3. PubMed ID: 9117092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.